Filing Details
- Accession Number:
- 0001209191-22-002457
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-07 17:10:47
- Reporting Period:
- 2021-12-01
- Accepted Time:
- 2022-01-07 17:10:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1075050 | J A Kazimi | 2525 West End Ave. Suite 950 Nashville TN 37203 | Chairman And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-12-01 | 18 | $4.14 | 5,770,187 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-02 | 18 | $3.84 | 5,770,205 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-03 | 18 | $4.47 | 5,770,223 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-06 | 18 | $4.46 | 5,770,241 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-07 | 18 | $5.61 | 5,770,259 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-08 | 18 | $6.15 | 5,770,277 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-09 | 18 | $5.81 | 5,770,295 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-10 | 18 | $4.82 | 5,770,313 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-13 | 30 | $4.36 | 5,770,343 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-14 | 30 | $4.28 | 5,770,373 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-15 | 30 | $4.29 | 5,770,403 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-16 | 50 | $4.53 | 5,770,453 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-17 | 50 | $4.17 | 5,770,503 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-12-20 | 60 | $4.33 | 5,770,563 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Billionaire Hedge Funds
